New Paper (Other): Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)

[agitter]

Title: Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)

General Information

Please paste a link to the paper or a citation here:

Link: https://doi.org/10.1101/2022.03.22.22271707

What is the paper's Manubot-style citation?

Citation: doi:10.1101/2022.03.22.22271707

Is this paper primarily relevant to Background or Pathogenesis?

• Background
• Pathogenesis
• Methods

Please list some keywords (3-10) that help identify the relevance of this paper to COVID-19

• vitamin D

Please note the publication / review status

• Pre-print
• New Peer-Reviewed Paper
• Peer-Reviewed Paper Pre-2020

Which areas of expertise are particularly relevant to the paper?

• virology
• epidemiology
• biostatistics
• immunology
• pharmacology
• other:

Summary

A large clinical trial studying vitamin D insufficiency. See also the blog summary at https://gidmk.medium.com/vitamin-d-supplementation-probably-doesnt-prevent-covid-19-1779a3e77901

@RLordan what do you think of this? Should we add it to the nutraceuticals manuscript (after getting the other high priority manuscripts submitted?).

Suggested questions to answer about each paper:

• What did they analyze?
• What methods did they use?
• Does this paper study COVID-19, SARS-CoV-2, or a related disease and/or virus?
• What is the main finding (or a few main takeaways)?
• What does this paper tell us about the background and/or diagnostics/therapeutics for COVID-19 / SARS-CoV-2?
• Do you have any concerns about methodology or the interpretation of these results beyond this analysis?

Any comments or notes?

[RLordan]

Hey @agitter, yes I agree. There has been a lot of movement in this space but little forward advancement on any potential prophylactics or therapeutics.